Advances in the study of exosomes derived from mesenchymal stem cells and cardiac cells for the treatment of myocardial infarction DOI Creative Commons
Yu‐Chang Liu,

Minrui Wang,

Yu Yang

et al.

Cell Communication and Signaling, Journal Year: 2023, Volume and Issue: 21(1)

Published: Aug. 14, 2023

Acute myocardial infarction has long been the leading cause of death in coronary heart disease, which is characterized by irreversible cardiomyocyte and restricted blood supply. Conventional reperfusion therapy can further aggravate injury. Stem cell therapy, especially with mesenchymal stem cells (MSCs), emerged as a promising approach to promote cardiac repair improve function. MSCs may induce these effects secreting exosomes containing therapeutically active RNA, proteins lipids. Notably, normal function depends on intracardiac paracrine signaling via exosomes, secreted partially reflect changes during so analyzing vesicles provide valuable insights into pathology well guide development new treatments. The present review examines how produced influence injury after serve therapies against such Video Abstract.

Language: Английский

Clinical applications of stem cell-derived exosomes DOI Creative Commons
Fei Tan, Xuran Li, Zhao Wang

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2024, Volume and Issue: 9(1)

Published: Jan. 12, 2024

Abstract Although stem cell-based therapy has demonstrated considerable potential to manage certain diseases more successfully than conventional surgery, it nevertheless comes with inescapable drawbacks that might limit its clinical translation. Compared cells, cell-derived exosomes possess numerous advantages, such as non-immunogenicity, non-infusion toxicity, easy access, effortless preservation, and freedom from tumorigenic ethical issues. Exosomes can inherit similar therapeutic effects their parental cells embryonic adult through vertical delivery of pluripotency or multipotency. After a thorough search meticulous dissection relevant literature the last five years, we present this comprehensive, up-to-date, specialty-specific disease-oriented review highlight surgical application exosomes. derived (e.g., embryonic, induced pluripotent, hematopoietic, mesenchymal, neural, endothelial cells) are capable treating encountered in orthopedic neurosurgery, plastic general cardiothoracic urology, head neck ophthalmology, obstetrics gynecology. The diverse cells-derived hierarchical translation tissue-specific responses, cell-specific molecular signaling pathways. In review, viable potent alternative managing various conditions. We recommend future research combines wisdoms surgeons, nanomedicine practitioners, cell researchers intriguing area.

Language: Английский

Citations

216

Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential DOI Creative Commons
Zhengjun Lin, Yanlin Wu, Yiting Xu

et al.

Molecular Cancer, Journal Year: 2022, Volume and Issue: 21(1)

Published: Sept. 13, 2022

Abstract Mesenchymal stem cells (MSCs) are multipotent stromal that can be obtained from various human tissues and organs. They differentiate into a wide range of cell types, including osteoblasts, adipocytes chondrocytes, thus exhibiting great potential in regenerative medicine. Numerous studies have indicated MSCs play critical roles cancer biology. The crosstalk between tumour has been found to regulate many behaviours, such as proliferation, metastasis epithelial-mesenchymal transition (EMT). Multiple lines evidence demonstrated secrete exosomes modulate the microenvironment important development. Notably, very recent works shown mesenchymal cell-derived (MSC-derived exosomes) critically involved resistance chemotherapy agents, targeted-therapy drugs, radiotherapy immunotherapy. In this review, we systematically summarized emerging detailed molecular mechanisms MSC-derived mediating therapy resistance, providing novel insights clinical applications management.

Language: Английский

Citations

170

Exosomes based strategies for brain drug delivery DOI
Fawad Ur Rehman, Yang Liu, Meng Zheng

et al.

Biomaterials, Journal Year: 2022, Volume and Issue: 293, P. 121949 - 121949

Published: Dec. 8, 2022

Language: Английский

Citations

120

Current understanding of plant-derived exosome-like nanoparticles in regulating the inflammatory response and immune system microenvironment DOI Creative Commons

Qiaoli Yi,

Zhijie Xu, Abhimanyu Thakur

et al.

Pharmacological Research, Journal Year: 2023, Volume and Issue: 190, P. 106733 - 106733

Published: March 15, 2023

Natural compounds are widely used to prevent and treat various diseases due their antioxidant anti-inflammatory effects. As a kind of promising natural compound, plant-derived exosome-like nanoparticles (PELNs) extracted from multivesicular bodies edible plants, including vegetables, foods, fruits, mainly regulate the cellular immune response pathogen attacks. Moreover, PELNs could remarkably interfere with dynamic imbalance between pro-inflammatory effects, facilitating maintain homeostasis microenvironment. may serve as better alternative animal-derived exosomes (ADEs) owing widespread sources, cost-effectiveness, easy accessibility. can mediate interspecies communication by transferring cargoes such proteins, lipids, nucleic acids plant cells mammalian cells. This review summarizes biogenesis, composition, classification exosomes; common separation, purification, characterization methods PELNs, potential advantages over ADEs; immunomodulatory functions in colitis, cancer, inflammation-associated metabolic diseases. Additionally, future perspectives challenges associated clinical application discussed.

Language: Английский

Citations

87

Extracellular vesicles: Emerging tools as therapeutic agent carriers DOI Creative Commons
Shan Liu,

Xue Wu,

Sutapa Chandra

et al.

Acta Pharmaceutica Sinica B, Journal Year: 2022, Volume and Issue: 12(10), P. 3822 - 3842

Published: May 11, 2022

Extracellular vesicles (EVs) are secreted by both eukaryotes and prokaryotes, present in all biological fluids of vertebrates, where they transfer DNA, RNA, proteins, lipids, metabolites from donor to recipient cells cell-to-cell communication. Some EV components can also indicate the type status their parent serve as diagnostic targets for liquid biopsy. EVs natively carry or be modified contain therapeutic agents (e.g., nucleic acids, polysaccharides, small molecules) physical, chemical, bioengineering strategies. Due excellent biocompatibility stability, ideal nanocarriers bioactive ingredients induce signal transduction, immunoregulation, other effects, which targeted specific cell types. Herein, we review classification, intercellular communication, isolation, characterization strategies apply therapeutics. This focuses on recent advances applications carriers vitro research towards vivo animal models early clinical applications, using representative examples fields cancer chemotherapeutic drug, vaccine, infectious disease vaccines, regenerative medicine gene therapy. Finally, discuss current challenges therapeutics future development.

Language: Английский

Citations

85

Extracellular vesicles: Emerging frontiers in wound healing DOI
Mangesh Dattu Hade, Caitlin N. Suire,

James Mossell

et al.

Medicinal Research Reviews, Journal Year: 2022, Volume and Issue: 42(6), P. 2102 - 2125

Published: June 27, 2022

Abstract Extracellular vesicles are membranous particles, ranging from 30 nm to 10 µm in diameter, which released by nearly all cell types aid intercellular communication. These complex carry a multitude of signaling moieties their origin, such as proteins, lipids, surface receptors, enzymes, cytokines, metabolites, and nucleic acids. A growing body evidence suggests that addition delivering cargos into target cells facilitate communication, extracellular may also play roles processes differentiation proliferation, angiogenesis, stress response, immune signaling. As these have natural biocompatibility, stability circulation, low toxicity, immunogenicity, serve efficient carriers molecular cargos, nanoparticles ideal therapeutic candidates for regenerative medicine. Exploring identifying the homeostatic functions development new therapies. In this review, we summarize wound healing process, difficulties stem therapies medicine, applications mesenchymal stromal cell‐derived improving accelerating process.

Language: Английский

Citations

85

Engineered Extracellular Vesicles with SHP2 High Expression Promote Mitophagy for Alzheimer's Disease Treatment DOI
Fang Xu, Yi Wu, Qianyu Yang

et al.

Advanced Materials, Journal Year: 2022, Volume and Issue: 34(49)

Published: Oct. 4, 2022

Mitochondrial dysfunction is a fundamental pathological feature of Alzheimer's disease (AD). However, toxicity and poor brain enrichment existing mitophagy inducers limit their further applications. In this study, platform for AD therapy developed using nanosized mesenchymal-stem-cells-derived extracellular vesicles with tyrosine phosphatase-2 (SHP2) high-expression (MSC-EVs-SHP2). The high blood-brain barrier penetration ability MSC-EVs-SHP2 demonstrated in AD-mice, facilitating SHP2 delivery to the brain. addition, significantly induces neuronal cells, which alleviates mitochondrial damage-mediated apoptosis NLRP3 inflammasome activation. Mitophagy diminishes cells neuroinflammation, culminating rescued synaptic loss cognitive decline an mouse model. EV-engineering technology provides potential effective by inducing mitophagy.

Language: Английский

Citations

82

Application of stem cells in regeneration medicine DOI Creative Commons
Ye Jin, Shuangyang Li,

Qixuan Yu

et al.

MedComm, Journal Year: 2023, Volume and Issue: 4(4)

Published: June 17, 2023

Abstract Regeneration is a complex process affected by many elements independent or combined, including inflammation, proliferation, and tissue remodeling. Stem cells class of primitive with the potentiality differentiation, regenerate self‐replication, multidirectional immunomodulatory functions. their cytokines not only inextricably linked to regeneration ectodermal skin tissues, but also can be used for treatment variety chronic wounds. produce exosomes in paracrine manner. cell play an important role regeneration, repair, accelerated wound healing, biological properties which are similar stem cells, while safer more effective. Skin bone tissues critical organs body, essential sustaining life activities. The weak repairing ability leads pronounced impact on quality patients, could alleviated treatment. However, there obstacles that trough improved bioavailability. This paper summarizes applications mechanisms healing. We propose new ways utilizing through different nanoformulations, liposomes nanoliposomes, polymer micelles, microspheres, hydrogels, scaffold microneedles, improve use healing regeneration.

Language: Английский

Citations

59

Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells-derived exosomes in patients with mild to moderate Alzheimer’s disease: a phase I/II clinical trial DOI Creative Commons

Xinyi Xie,

Qingxiang Song,

Chengxiang Dai

et al.

General Psychiatry, Journal Year: 2023, Volume and Issue: 36(5), P. e101143 - e101143

Published: Oct. 1, 2023

There have been no effective treatments for slowing or reversing Alzheimer's disease (AD) until now. Growing preclinical evidence, including this study, suggests that mesenchymal stem cells-secreted exosomes (MSCs-Exos) the potential to cure AD.

Language: Английский

Citations

57

Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification DOI Creative Commons

Qisong Liu,

Defeng Li, Xiaohua Pan

et al.

Journal of Nanobiotechnology, Journal Year: 2023, Volume and Issue: 21(1)

Published: Sept. 16, 2023

Abstract Extracellular vesicles (EVs) are 30–150 nm membrane-bound naturally secreted by cells and play important roles in intercellular communication delivering regulatory molecules such as proteins, lipids, nucleic acids metabolites to recipient cells. As natural nano-carriers, EVs possess desirable properties high biocompatibility, biological barrier permeability, low toxicity, immunogenicity, making them potential therapeutic delivery vehicles. derived from specific have inherent targeting capacity towards cell types, which is yet not satisfactory enough for targeted therapy development needs be improved. Surface modifications endow with abilities, significantly improving their efficiency. Herein, we first briefly introduce the biogenesis, composition, uptake function of EVs, review cargo loading approaches EVs. Then, summarize recent advances surface engineering strategies focusing on applications engineered therapy. Altogether, hold great promise various cargos, show promising effects multiple diseases. Graphical

Language: Английский

Citations

56